loadpatents
name:-0.013370037078857
name:-0.010591983795166
name:-0.00047016143798828
ARTUSI; Roberto Patent Filings

ARTUSI; Roberto

Patent Applications and Registrations

Patent applications and USPTO patent grants for ARTUSI; Roberto.The latest application filed is for "benzo-and pyrido-pyrazoles as protein kinase inhibitors".

Company Profile
0.10.13
  • ARTUSI; Roberto - Rho IT
  • Artusi; Roberto - Monza IT
  • Artusi; Roberto - Rho Milano
  • Artusi; Roberto - Rho Milan IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzo-and Pyrido-pyrazoles As Protein Kinase Inhibitors
App 20220041559 - Rovati; Lucio Claudio ;   et al.
2022-02-10
FYN kinase inhibitors
Grant 10,125,121 - Artusi , et al. November 13, 2
2018-11-13
New Fyn Kinase Inhibitors
App 20180111919 - ARTUSI; Roberto ;   et al.
2018-04-26
4,4-difluoro-piperidine-compounds
Grant 9,493,438 - Stasi , et al. November 15, 2
2016-11-15
Chemical compounds
Grant 9,062,033 - Stasi , et al. June 23, 2
2015-06-23
4,4-difluoro-piperidine-compounds
App 20150051226 - Stasi; Luigi Piero ;   et al.
2015-02-19
Chemical Compounds
App 20140357653 - Stasi; Luigi Piero ;   et al.
2014-12-04
2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain
Grant 8,372,866 - Giordani , et al. February 12, 2
2013-02-12
Pyrrole derivatives with angiotensin II antagonist activity
Grant 7,906,501 - Makovec , et al. March 15, 2
2011-03-15
2-aryl And 2-heteroaryl 4h-1-benzopyran-4-one-6-amidino Derivatives, New Pharmacological Agents For The Treatment Of Arthritis, Cancer And Related Pain
App 20110003861 - Giordani; Antonio ;   et al.
2011-01-06
Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
App 20100120802 - MAKOVEC; Francesco ;   et al.
2010-05-13
Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
Grant 7,674,809 - Makovec , et al. March 9, 2
2010-03-09
Benzamidine derivatives having anti-inflammatory and immunosuppressive activity
Grant 7,560,591 - Makovec , et al. July 14, 2
2009-07-14
Novel Benzamidine Derivatives Having Anti-Inflammatory and Immunosuppressive Activity
App 20080207764 - Makovec; Francesco ;   et al.
2008-08-28
Benzamidine Derivatives for Treatment and Prevention of Cancer Therapy Induced Mucositis
App 20080194877 - Letari; Ornella ;   et al.
2008-08-14
Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity
App 20070244170 - Makovec; Francesco ;   et al.
2007-10-18
Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
App 20070135523 - Makovec; Francesco ;   et al.
2007-06-14
Benzamidine derivatives having anti-inflammatory and immunosuppressive activity
Grant 7,202,277 - Makovec , et al. April 10, 2
2007-04-10
Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
Grant 7,145,037 - Makovec , et al. December 5, 2
2006-12-05
Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
App 20050197331 - Makovec, Francesco ;   et al.
2005-09-08
Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities,and process for preparing them
App 20050049312 - Makovec, Francesco ;   et al.
2005-03-03
Novel benzamidine derivatives having anti-inflammatory and immunosuppressive
App 20040110801 - Makovec, Franscesco ;   et al.
2004-06-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed